Detection of cancer by elevated levels of bcl-2
AssigneeUniversity of South Florida
InventorPatricia A. Kruk
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of South Florida
InventorPatricia A. Kruk
Estimating the term…
The present invention relates to a method for the diagnosis, prognosis, and monitoring of cancer, such as early or late stage ovarian cancer, in a subject by detecting Bcl-2 in a biological sample from the subject, preferably a urine or blood sample. Bcl-2 may be measured using an agent that detects or binds to Bcl-2 protein or an agent that detects or binds to encoding nucleic acids, such as antibodies specifically reactive with Bcl-2 protein or a portion thereof. The invention further relates to kits for carrying out the methods of the invention. The invention further relates to a device for the rapid detection of Bcl-2 in a bodily fluid and methods for rapidly measuring Bcl-2 in a bodily fluid.
A method for determining a Bcl-2 protein level in a urine sample from a subject, the method comprising:
Dependencies are inferred from the claim text.